Series D financing round of $ 37.5 million was closed by RainDance Technologies, a specialist for microdroplet-based solutions for single molecule and single cell analysis. The financing was co-led by new investor Quaker BioVentures and existing investor Mohr Davidow Ventures. Existing investors Alloy Ventures and Acadia Woods also participated in the financing round. Sherrill Neff from Quaker BioVentures and Jeffrey Samberg from Acadia Woods will join the RainDance Board of Directors.
The Company will use the funding to drive new applications for its commercial targeted sequencing and sequence enrichment solution in the medical genetics and research markets, as well as grow the Company's global sales and support infrastructure. In addition, RainDance will use this funding to develop and commercialize industry-leading products for single molecule digital PCR and single cell analysis.
Related Articles :
Keywords : Automation Cells High Throughput Jeffrey Samberg Lif Science Microdroplet Ontario Brain Institute PCR Screening Sequencing Sherrill Neff
Reader comments (0)